January 7, 2015
In this 2015 video, Dr. Lazar talks about what CAP cancer biomarker reporting templates are and how they are used
Watch as Dr. Alexander Lazar talks about using CAP cancer biomarker reporting templates. He also covers the problems with biomarker reporting and reporting with the melanoma template.
Alexander Lazar, MD, PhD, is a Professor in the Pathology department at the University of Texas (UT) M.D. Anderson Cancer Center in Houston, Texas, U.S.A. He entered the NIH-sponsored Medical Scientist Training Program at UT Southwestern in Dallas, Texas. He completed Anatomic Pathology residency at Brigham and Women’s Hospital, Harvard Medical School in Boston, Massachusetts and a fellowship in Soft Tissue Pathology. He completed a Dermatopathology fellowship at Massachusetts General Hospital in Boston. He is founding Director of the ACGME accredited Soft Tissue Pathology fellowship program. He has held leadership positions within the American Joint Committee on Cancer (AJCC) for sarcoma staging and the College of American Pathologists (CAP). He participated in producing the 2013 World Health Organization (WHO) classification system for bone and soft-tissue tumors.
Watch the video for the CAP education session about cancer biomarker reporting templates
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.